50/FIFTY

Today's stories, rewritten neutrally

Politics5d ago

Trump Administration Considers Policy Changes for 401(k)s and Psychedelic Research

The Trump administration is exploring allowing alternative investments in retirement accounts and loosening restrictions on psychedelic medicine research.

Synthesized from 3 sources

The Trump administration is reportedly considering policy changes that would expand investment options in 401(k) retirement plans to include alternative assets such as private equity and cryptocurrency. The potential changes would represent a significant shift in how Americans could invest their retirement savings.

Currently, most 401(k) plans offer traditional investment options like mutual funds, index funds, and company stock. The proposed changes would allow plan administrators to include private equity investments and digital assets on their investment menus, giving workers access to asset classes previously available primarily to wealthy investors and institutions.

Separately, President Trump has signed an executive order aimed at loosening federal restrictions on psychedelic medicine research. The order was reportedly influenced by a text message from podcast host Joe Rogan and represents a potential shift in the government's approach to psychedelic drugs for medical purposes.

Advocates for psychedelic research expressed cautious optimism about the development, viewing it as a step toward legitimizing an industry that has operated with limited federal support. Researchers have been studying the potential therapeutic benefits of substances like psilocybin and MDMA for treating conditions including depression, PTSD, and other mental health disorders.

Both policy areas involve regulatory frameworks that have traditionally been restrictive. The 401(k) changes would require coordination with the Department of Labor and other agencies that oversee retirement plan regulations. The psychedelic research order would need additional implementation measures to translate into meaningful changes for researchers and medical practitioners.

Sources (3)

Bias Scale:
LeftCenterRight

Comments

No comments yet. Be the first!